Please login to the form below

Not currently logged in
Email:
Password:

Management team buys out Wells Healthcare and Quantum Medical

An internal management team has initiated a majority buy-out of Interlace Global, the holding company for Wells Healthcare and Quantum Medical Communications

An internal management team of UK-based global medical communications agency, Interlace Global, has initiated a majority buy-out of Interlace Global, which is the holding company for both medical communications company, Wells Healthcare, and regulatory and pharmacovigilance medical writing agency, Quantum Medical Communications.

Wells and Quantum provide pharmaceutical communications for clients requiring science, increased senior counsel and strategic publication planning or developing relationships with key opinion leaders. Other services are a thorough understanding of the requirements of pharmacovigilance, risk management and regulatory strategy before launch.

Two senior members of the management team have taken a majority shareholding and have joined the board: Mark Forbes Irving, as managing director, and Vanita Buxton, as finance director. Andrew Wright, former majority shareholder and Chairman of both companies, will continue as a director.

Andrew Wright said of the buy out: "I am very pleased to take this major step for the business after 25 years of family ownership. Mark and Vanita have won my confidence over the past few years. By extending both the ownership and management of Wells Healthcare and Quantum Medical, I believe the business will continue to grow and provide exceptional client delivery. The benefits to clients are absolute continuity, enhanced management direction and sustained high levels of service."

Forbes Irving, managing director, added: "Interlace Global is a powerhouse of understanding and delivery and is one of the premier independent global communications groups. As such, it is uniquely placed to deliver excellence in integrated healthcare communications."

Wells has a staff of 33 people, with three more senior appointments to be announced in due course. Quantum's team comprises ten full-time members and is also currently expanding its in-house capabilities. Clients across both companies include the majority of the top 25 global research based pharmaceutical companies.

5th April 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics